AGL vs. GILD
AGL (agilon health, inc.) and GILD (Gilead Sciences, Inc.) are both stocks. Both are in the Healthcare sector — AGL in Medical Care Facilities, GILD in Drug Manufacturers - General. Over the past 5 years, AGL returned -36.95%/yr vs 18.01%/yr for GILD. Their 0.11 correlation means their historical movements had little consistent relationship.
Performance
AGL vs. GILD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AGL achieves a 432.07% return, which is significantly higher than GILD's 7.39% return.
AGL
- 1D
- -5.31%
- 1M
- -17.48%
- 6M
- 340.33%
- YTD
- 432.07%
- 1Y
- 115.55%
- 3Y*
- -41.50%
- 5Y*
- -36.95%
- 10Y*
- —
- ALL TIME*
- -32.02%
GILD
- 1D
- -0.82%
- 1M
- -0.81%
- 6M
- -7.14%
- YTD
- 7.39%
- 1Y
- 18.04%
- 3Y*
- 23.83%
- 5Y*
- 18.01%
- 10Y*
- 8.84%
- ALL TIME*
- 18.51%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $31.50M | $33.68M | $35.49M | |
| $811.25M | $879.82M | $985.54M |
AGL vs. GILD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
AGL agilon health, inc. | 432.07% | -63.75% | -84.86% | -22.24% | -40.22% | -4.42% |
GILD Gilead Sciences, Inc. | 7.39% | 36.59% | 18.68% | -1.99% | 23.63% | 14.64% |
Correlation
The correlation between AGL and GILD is 0.04, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.04 |
Correlation (3Y) Balances recent behavior with more history. | 0.10 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.12 |
Correlation (All Time) Calculated using the full available price history since Apr 15, 2021 | 0.11 |
Fundamentals
AGL:
$1.53B
GILD:
$161.66B
AGL:
-$22.49
GILD:
$7.35
AGL:
0.26
GILD:
5.49
AGL:
8.41
GILD:
6.94
AGL:
$5.82B
GILD:
$29.74B
AGL:
-$225.14M
GILD:
$18.74B
AGL:
-$340.64M
GILD:
$12.88B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AGL vs. GILD — Risk / Return Rank
AGL
GILD
AGL vs. GILD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for agilon health, inc. (AGL) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AGL | GILD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.11 | ||
| Sortino ratioReturn per unit of downside risk | +1.00 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.14 | +0.17 |
| Calmar ratioReturn relative to maximum drawdown | 1.28 | 0.88 | +0.39 |
| Martin ratioReturn relative to average drawdown | 2.15 | 2.01 | +0.14 |
Loading charts...
Drawdowns
AGL vs. GILD - Drawdown Comparison
The maximum AGL drawdown since its inception was -99.27%, which is greater than GILD's maximum drawdown of -70.83%. Use the drawdown chart below to compare losses from any high point for AGL and GILD.
Loading charts...
Drawdown Indicators
| AGL | GILD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.27% | -70.83% | -28.44% |
Max Drawdown (1Y)Largest decline over 1 year | -82.57% | -21.59% | -60.98% |
Max Drawdown (3Y)Largest decline over 3 years | -98.43% | -26.59% | -71.84% |
Max Drawdown (5Y)Largest decline over 5 years | -99.18% | -26.59% | -72.59% |
Max Drawdown (10Y)Largest decline over 10 years | — | -30.47% | — |
Current DrawdownCurrent decline from peak | -91.53% | -15.40% | -76.13% |
Average DrawdownAverage peak-to-trough decline | -68.39% | -22.13% | -46.26% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 48.89% | 9.47% | +39.42% |
Volatility
AGL vs. GILD - Volatility Comparison
agilon health, inc. (AGL) has a higher volatility of 25.02% compared to Gilead Sciences, Inc. (GILD) at 10.07%. This indicates that AGL's price experiences larger fluctuations and is considered to be riskier than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AGL | GILD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.02% | 10.07% | +14.95% |
Volatility (6M)Calculated over the trailing 6-month period | 126.81% | 19.28% | +107.53% |
Volatility (1Y)Calculated over the trailing 1-year period | 175.68% | 27.06% | +148.62% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 103.70% | 24.54% | +79.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 101.49% | 25.46% | +76.03% |
Dividends
AGL vs. GILD - Dividend Comparison
AGL has not paid dividends to shareholders, while GILD's dividend yield for the trailing twelve months is around 2.47%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AGL agilon health, inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GILD Gilead Sciences, Inc. | 2.47% | 2.57% | 3.33% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% |
Financials
AGL vs. GILD - Financials Comparison
This section allows you to compare key financial metrics between agilon health, inc. and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AGL vs. GILD - Profitability Comparison
AGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, agilon health, inc. reported a gross profit of 0.00 and revenue of 1.42B. Therefore, the gross margin over that period was 0.0%.
GILD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Gilead Sciences, Inc. reported a gross profit of 79.20M and revenue of 6.96B. Therefore, the gross margin over that period was 1.1%.
AGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, agilon health, inc. reported an operating income of 4.00M and revenue of 1.42B, resulting in an operating margin of 0.3%.
GILD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Gilead Sciences, Inc. reported an operating income of 2.59B and revenue of 6.96B, resulting in an operating margin of 37.2%.
AGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, agilon health, inc. reported a net income of 29.97M and revenue of 1.42B, resulting in a net margin of 2.1%.
GILD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Gilead Sciences, Inc. reported a net income of 2.02B and revenue of 6.96B, resulting in a net margin of 29.0%.
Frequently Asked Questions
AGL and GILD have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AGL has higher volatility (25.02%) compared to GILD (10.07%). In terms of maximum drawdown, AGL dropped -99.27% vs GILD's -70.83%.
GILD currently has the higher Sharpe Ratio (0.71 vs 0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AGL and GILD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer